PsychExchange
Adrienne Jo
Host
Adrienne Jo is a Neuropharmacology PhD Candidate in the labs of Drs. Gregory Corder & Julie Blendy at the University of Pennsylvania. Her thesis research aims to characterize brain-wide connectivity of mu-opioid-receptor neural networks across various timepoints of opioid use disorder in mice. She has also actively supported life sciences bioentrepreneurs as Co-Managing Director of Nucleate Philadelphia, a student-led non-profit global organization that facilitates the formation of pioneering academic-based life sciences ventures. Moreover, Adrienne has had the great privilege of interacting with leading psychedelic founders as a VC Fellow at Palo Santo. Through her experiences, Adrienne has come to believe that psychedelic compounds have enormous potential in revolutionizing our treatment paradigms in a myriad of CNS disorders.
Sophie Rogers
Host
Sophie Rogers is a Neuroscience Ph.D. candidate at the University of Pennsylvania in the laboratory of Dr. Gregory Corder, where she studies the neural circuits and dynamics underlying psilocybin-assisted fear extinction in mice. Prior to her studies at UPenn, Sophie spent seven years studying the neuroscience of addiction at Weill Cornell Medical School, the University of Chicago (B.S.), and Mount Sinai Hospital, but she always wondered more broadly how drugs can induce persistent changes in consciousness and motivation through actions at neural circuits. Now, she uses techniques such as in vivo single cell calcium imaging, chemogenetics, and in-situ hybridization to capture the behaviorally relevant effects of psilocybin on cortical serotonin receptor-expressing neurons.